CDX 50 Trademark

Trademark Overview

On Wednesday, May 29, 2002, a trademark application was filed for CDX 50 with the United States Patent and Trademark Office. The USPTO has given the CDX 50 trademark a serial number of 76413298. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, November 20, 2017. This trademark is owned by AstraZeneca UK Limited. The CDX 50 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment [ and/or prevention ] of cancer
cdx 50

General Information

Serial Number76413298
Word MarkCDX 50
Filing DateWednesday, May 29, 2002
Status800 - REGISTERED AND RENEWED
Status DateMonday, November 20, 2017
Registration Number3344593
Registration DateTuesday, November 27, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 30, 2003

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined TextTHE REPRESENTATION OF THE TABLET
Description of MarkThe mark consists of the notation "CDX 50" and a stylized arrow device which appear on the opposite faces of pharmaceutical tablets. The matter shown by the dotted lines is not part of the mark and serves only to show the position of the mark on the goods.
Goods and ServicesPharmaceutical preparations and substances for the treatment [ and/or prevention ] of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2002
Primary Code005
First Use Anywhere DateTuesday, October 31, 2006
First Use In Commerce DateTuesday, October 31, 2006

Trademark Owner History

Party NameAstraZeneca UK Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCambridge CB2 0AA
GB
Party NameAstraZeneca UK Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLondon, W1Y 6LN
Party NameAstraZeneca UK Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLondon, W1Y 6LN

Trademark Events

Event DateEvent Description
Monday, November 20, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, November 20, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, November 20, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, November 20, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 24, 2017TEAS SECTION 8 & 9 RECEIVED
Tuesday, October 24, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 27, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, November 24, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 23, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 12, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Saturday, November 23, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 12, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 27, 2007REGISTERED-PRINCIPAL REGISTER
Friday, October 19, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, October 19, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 18, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 18, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 18, 2007ASSIGNED TO LIE
Friday, September 14, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 30, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 30, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 14, 2007NON-FINAL ACTION MAILED
Wednesday, March 14, 2007SU - NON-FINAL ACTION - WRITTEN
Saturday, March 10, 2007STATEMENT OF USE PROCESSING COMPLETE
Friday, December 22, 2006USE AMENDMENT FILED
Friday, December 22, 2006TEAS STATEMENT OF USE RECEIVED
Wednesday, June 21, 2006EXTENSION 5 GRANTED
Wednesday, June 21, 2006EXTENSION 5 FILED
Wednesday, June 21, 2006TEAS EXTENSION RECEIVED
Friday, December 23, 2005EXTENSION 4 GRANTED
Friday, December 23, 2005EXTENSION 4 FILED
Friday, December 23, 2005TEAS EXTENSION RECEIVED
Thursday, June 23, 2005EXTENSION 3 GRANTED
Thursday, June 23, 2005EXTENSION 3 FILED
Thursday, June 23, 2005TEAS EXTENSION RECEIVED
Thursday, January 13, 2005EXTENSION 2 GRANTED
Thursday, December 23, 2004EXTENSION 2 FILED
Thursday, December 23, 2004TEAS EXTENSION RECEIVED
Friday, July 9, 2004EXTENSION 1 GRANTED
Wednesday, June 23, 2004EXTENSION 1 FILED
Wednesday, June 23, 2004TEAS EXTENSION RECEIVED
Tuesday, December 23, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 30, 2003PUBLISHED FOR OPPOSITION
Wednesday, September 10, 2003NOTICE OF PUBLICATION
Tuesday, August 5, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 19, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 7, 2003CASE FILE IN TICRS
Thursday, June 19, 2003PAPER RECEIVED
Tuesday, April 29, 2003FINAL REFUSAL MAILED
Monday, April 7, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 7, 2003PAPER RECEIVED
Wednesday, February 5, 2003NON-FINAL ACTION MAILED
Wednesday, November 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 20, 2002PAPER RECEIVED
Wednesday, September 18, 2002NON-FINAL ACTION MAILED
Tuesday, September 10, 2002ASSIGNED TO EXAMINER

Related Keywords

prevention cancer treatment substances preparations pharmaceutical